Phospho-Sulindac (OXT-328) Inhibits Dry Eye Disease in Rabbits: A Dose-, Formulation- and Structure-Dependent Effect

Huang, W; Wen, ZY; Saglam, MS; Huang, LQ; Honkanen, RA; Rigas, B

Rigas, B (corresponding author), SUNY Stony Brook, Dept Prevent Med, Stony Brook, NY 11794 USA.

JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2021; 37 (6): 321

Abstract

Purpose: Inflammation of the ocular surface is central to dry eye disease (DED). The anti-inflammatory agent phospho-sulindac (PS) at a high dose was ......

Full Text Link